These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 32206949)
101. ASO Author Reflections: The Impact of Local Therapy on Non-metastatic Esophageal Cancer. Parsons M; Tao R Ann Surg Oncol; 2020 Dec; 27(Suppl 3):818-819. PubMed ID: 32661851 [No Abstract] [Full Text] [Related]
102. [Pathological diagnosis of superficial esophageal squamous cell carcinoma and superficial squamous cell carcinoma of head and neck]. Fujii S; Sunakawa H; Kadota T Nihon Shokakibyo Gakkai Zasshi; 2018; 115(10):862-867. PubMed ID: 30305567 [No Abstract] [Full Text] [Related]
103. [French comment on article Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma]. Endoscopy; 2018 Jul; 50(7):736. PubMed ID: 29949824 [No Abstract] [Full Text] [Related]
104. ASO Author Reflections: Gastrointestinal Symptoms After Esophagectomy or Gastrectomy Do Not Represent a Temporary Problem. van Erning FN; Vissers PAJ Ann Surg Oncol; 2023 Dec; 30(13):8588-8589. PubMed ID: 37490164 [No Abstract] [Full Text] [Related]
105. ASO Author Reflections: Minimally Invasive Ivor-Lewis Esophagectomy for Esophageal Cancer After Gastric Bypass. Latzko M; Awad Z Ann Surg Oncol; 2020 Dec; 27(Suppl 3):793-794. PubMed ID: 32588267 [No Abstract] [Full Text] [Related]
106. ASO Author Reflections: Wives as Key Persons Positively Impact Prognosis for Male Patients Undergoing Esophagectomy for Esophageal Cancer: A Retrospective Study from a Single Japanese Institute. Yoshida N; Baba H Ann Surg Oncol; 2020 Jul; 27(7):2412-2413. PubMed ID: 32328987 [No Abstract] [Full Text] [Related]
107. ASO Author Reflections: R0 Resection After Oncologic Esophagectomy-Cutting on the Edge (0 cm) is Not Enough. St-Amour P; Schäfer M; Mantziari S Ann Surg Oncol; 2021 Nov; 28(12):7107-7108. PubMed ID: 34019182 [No Abstract] [Full Text] [Related]
108. ASO Author Reflections: The Role of Physiotherapy Regimens in Esophagectomy and Gastrectomy for Cancer. Tukanova K; Chidambaram S; Guidozzi N; Hanna GB; McGregor AH; Markar SR Ann Surg Oncol; 2022 May; 29(5):3168-3169. PubMed ID: 34897586 [No Abstract] [Full Text] [Related]
109. Very long-term outcomes of minimally invasive esophagectomy for esophageal squamous cell carcinoma. Zhu Y; Chen W J BUON; 2015; 20(6):1585-91. PubMed ID: 26854456 [TBL] [Abstract][Full Text] [Related]
110. Outcomes of operation for esophageal squamous cell carcinoma: Which approach is best? Ferraris VA J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1016-7. PubMed ID: 25659854 [No Abstract] [Full Text] [Related]
111. ASO Author Reflections: Clinical Benefit of Robot-Assisted Minimally Invasive Esophagectomy over Conventional Minimally Invasive Esophagectomy. Tsunoda S; Obama K Ann Surg Oncol; 2021 Feb; 28(2):648-649. PubMed ID: 32865622 [No Abstract] [Full Text] [Related]
112. ASO Author Reflections: How to Control Hypothyroidism and Hypoparathyroidism Following Pharyngo-Laryngo-Esophagectomy for Cervical Esophageal Cancer. Saito Y; Kawakubo H; Kitagawa Y Ann Surg Oncol; 2021 Dec; 28(Suppl 3):858-859. PubMed ID: 33704605 [No Abstract] [Full Text] [Related]
113. ASO Author Reflections: Smoking Status Impact on Perioperative Morbidity and Long-Term Survival of Patients Undergoing Esophagectomy for Cancer. Kamarajah SK; Phillips AW Ann Surg Oncol; 2021 Sep; 28(9):4916-4917. PubMed ID: 33666813 [No Abstract] [Full Text] [Related]
114. Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma. Kam AE; Pappas SG; Masood A Ann Surg Oncol; 2020 May; 27(5):1314-1315. PubMed ID: 31848823 [No Abstract] [Full Text] [Related]
115. ASO Author Reflections: The Road Ahead for cT2N0M0 Esophageal Adenocarcinoma. Rodriguez-Quintero JH; Stiles BM Ann Surg Oncol; 2024 Feb; 31(2):892-893. PubMed ID: 37882930 [No Abstract] [Full Text] [Related]
116. ASO Author Reflections: Establishment of an Ideal Criterion for Evaluating the Therapeutic Effect on Esophageal Cancer. Yoshida N; Eto K; Baba H Ann Surg Oncol; 2021 Dec; 28(13):8483-8484. PubMed ID: 34318386 [No Abstract] [Full Text] [Related]
117. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy. Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278 [TBL] [Abstract][Full Text] [Related]
118. Additional Esophagectomy Following Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Study. Liu Z; Zhang J; Su Y; Pan J; Yang Y; Huang B; Zhao J; Li Z Ann Surg Oncol; 2021 Nov; 28(12):7149-7159. PubMed ID: 34269944 [TBL] [Abstract][Full Text] [Related]
119. ASO Author Reflections: Delivery of Perioperative Chemotherapy for Esophageal Cancer in Routine Clinical Practice. Yan S; Liu XB; Xing WQ; Chen PN; Liu SL; Li P; Ma YX; Jiang D; Sun HB Ann Surg Oncol; 2024 Mar; 31(3):1587-1588. PubMed ID: 38093165 [No Abstract] [Full Text] [Related]
120. Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy. Chen P; Han L; Wang C; Jia Y; Song Q; Wang J; Guan S; Tan B; Liu B; Jia W; Cui J; Zhou W; Cheng Y Oncotarget; 2017 Jun; 8(25):41605-41619. PubMed ID: 28404928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]